Propel Bio Management, LLC / KLRS
Propel Bio Management, LLC’s Kalaris Therapeutics Inc Position
Does Propel Bio Management, LLC own Kalaris Therapeutics Inc (KLRS)? Yes — 295.8K shares worth $2M (+1.08% of its 13F portfolio) as of Q1 2026, up from 42.1K shares the prior filed quarter.
Position Value
$2M
Q1 2026
Shares
295.8K
% of Portfolio
+1.08%
Quarters Held
2
currently held
Position History KLRS
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of KLRS.